DrugPatentWatch Database Preview
Details for Patent: 7,220,247
Which drugs does patent 7,220,247 protect, and when does it expire?
Patent 7,220,247 protects ZOLADEX and is included in two NDAs.
This patent has fifty patent family members in thirty-three countries.
Summary for Patent: 7,220,247
| Title: | Automatically operable safety shield system for syringes |
| Abstract: | An automatically operable safety shield system for use with a syringe that comprises an inner holder in which said syringe may be inserted and an outer shield mounted outwards from the inner holder axially movable between retracted and extended positions in which a spring positioned between said inner holder and said outer shield urging the outer shield to its extended position and the inner holder having at least one first opening, distally thereto, at least one first indentation, and the outer shield having at least one first stop member engageable with the opening when the outer shield is in the retracted position engageable with the first indentation when the outer shield is in the extended position and the outer shield may be released from its retracted position by action of a trigger positioned within the inner holder or by protrusion on the syringe plunger. |
| Inventor(s): | Shaw; Derek J (Macclesfield, GB), Law; Brian R (Leicester, GB) |
| Assignee: | AstraZeneca AB (Sodertalje, SE) |
| Application Number: | 10/815,014 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 7,220,247
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tersera Theraps Llc | ZOLADEX | goserelin acetate | IMPLANT;IMPLANTATION | 019726-001 | Dec 29, 1989 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| Tersera Theraps Llc | ZOLADEX | goserelin acetate | IMPLANT;IMPLANTATION | 020578-001 | Jan 11, 1996 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,220,247
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| United Kingdom | 0003790.3 | Feb 18, 2000 |
International Family Members for US Patent 7,220,247
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 027445 | Start Trial | |||
| Austria | 344075 | Start Trial | |||
| Australia | 3209901 | Start Trial | |||
| Australia | 770373 | Start Trial | |||
| Bulgaria | 106938 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
